2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis

Autor: Alekseev, B., Yang, L., Alyasova, A., Ye, D., Karpenko, A., Li, H., Xie, L., Kurteva, G., Kowalyszyn, R., Karyakin, O., Neron, Y., Cosgriff, T., Collins, L., Brechenmacher, T., Lin, J., Morgan, L., Motzer, R.
Zdroj: In European Journal of Cancer September 2015 51 Supplement 3:S518-S519
Databáze: ScienceDirect
Externí odkaz: